insulin

Documents about insulin

• A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients#67837ClinicalTrials.gov
• Influence of Central Nervous Insulin Sensitivity on Insulin Secretion#343762ClinicalTrials.gov
• Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone#272289ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before#127787ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin#160258ClinicalTrials.gov
• Low Dose Fat-Induced Insulin Resistance#67799ClinicalTrials.gov
• Insulin Signaling in Skeletal Muscle#28572ClinicalTrials.gov
• Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases#275930PLOS
• A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance#279662ClinicalTrials.gov
• A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment#411365ClinicalTrials.gov
• Diabetes, Insulin Resistance and Body Composition#127766ClinicalTrials.gov
• Depression & Insulin Sensitivity in Adolescents#391039ClinicalTrials.gov
• Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man#6716OpenAlex
• Cacao Consumption in Patients With Insulin Resistance#268126ClinicalTrials.gov
• Effectiveness of Cinnamon on Insulin Resistance ( ECIRCCOS ) December 1, 2019#398290ClinicalTrials.gov
• Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance#184801ClinicalTrials.gov
• Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus#290911ClinicalTrials.gov
• U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod#394698ClinicalTrials.gov
• Insulin Resistance and Androgen Deprivation Therapy#127773ClinicalTrials.gov
• Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause#460070ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before#140961ClinicalTrials.gov
• Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin#162425ClinicalTrials.gov
• Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)#28529ClinicalTrials.gov
• Personalized Fiber and Insulin Sensitivity#311058ClinicalTrials.gov
• Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.#279468ClinicalTrials.gov
• Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment#429719ClinicalTrials.gov
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes#162363ClinicalTrials.gov
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients#67835ClinicalTrials.gov
• Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients#126073ClinicalTrials.gov
• Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring#343768ClinicalTrials.gov
• Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin#290942ClinicalTrials.gov
• Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women#429106WIReDSpace
• Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)#121276ClinicalTrials.gov
• Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients#429733ClinicalTrials.gov
• Video Training to Reduce Insulin Administration Errors#67800ClinicalTrials.gov
• Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females#279453ClinicalTrials.gov
• A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine#451442ClinicalTrials.gov
• A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes#158191ClinicalTrials.gov
• Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens#180336ClinicalTrials.gov
• Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes#283207ClinicalTrials.gov
• Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients#18539ClinicalTrials.gov
• Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion#126009ClinicalTrials.gov
• Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow#127747ClinicalTrials.gov
• Metformin Effect on Brain Function in Insulin Resistant Elderly People#184798ClinicalTrials.gov
• The Role of Insulin Resistance in PCOS#257051ClinicalTrials.gov
• Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance#287490ClinicalTrials.gov
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration#356621ClinicalTrials.gov
• The Effect of Brown Adipose Tissue Activation on Insulin Sensitivity in Humans#454163ClinicalTrials.gov
• Treating the Endothelium to Restore Insulin Sensitivity#460026ClinicalTrials.gov
• Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.#195500ClinicalTrials.gov

Related topics